Viking Therapeutics, Inc. Quarterly Common Stock, Shares, Outstanding from Q4 2014 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Viking Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2014 to Q2 2024.
  • Viking Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending June 30, 2024 was 111M shares, a 10.8% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 111M +10.8M +10.8% Jun 30, 2024 10-Q 2024-07-24
Q1 2024 110M +30.9M +39% Mar 31, 2024 10-Q 2024-04-25
Q4 2023 100M +21.9M +27.9% Dec 31, 2023 10-Q 2024-07-24
Q3 2023 100M +23.3M +30.4% Sep 30, 2023 10-Q 2023-10-25
Q2 2023 100M +23.3M +30.4% Jun 30, 2023 10-Q 2023-07-26
Q1 2023 79.3M +1.95M +2.51% Mar 31, 2023 10-Q 2023-04-26
Q4 2022 78.3M +8.86K +0.01% Dec 31, 2022 10-K 2024-02-07
Q3 2022 76.7M -1.55M -1.98% Sep 30, 2022 10-Q 2022-10-26
Q2 2022 76.7M -1.5M -1.92% Jun 30, 2022 10-Q 2022-07-27
Q1 2022 77.4M +196K +0.25% Mar 31, 2022 10-Q 2022-04-27
Q4 2021 78.2M +5.03M +6.87% Dec 31, 2021 10-K 2023-02-10
Q3 2021 78.2M +5.31M +7.29% Sep 30, 2021 10-Q 2021-11-03
Q2 2021 78.2M +5.43M +7.47% Jun 30, 2021 10-Q 2021-07-28
Q1 2021 77.2M +4.62M +6.36% Mar 31, 2021 10-Q 2021-04-28
Q4 2020 73.2M +802K +1.11% Dec 31, 2020 10-K 2022-02-09
Q3 2020 72.9M +666K +0.92% Sep 30, 2020 10-Q 2020-10-28
Q2 2020 72.8M +585K +0.81% Jun 30, 2020 10-Q 2020-07-29
Q1 2020 72.6M +535K +0.74% Mar 31, 2020 10-Q 2020-04-30
Q4 2019 72.4M +672K +0.94% Dec 31, 2019 10-K 2021-02-17
Q3 2019 72.3M +971K +1.36% Sep 30, 2019 10-Q 2019-11-05
Q2 2019 72.2M +11.5M +19% Jun 30, 2019 10-Q 2019-08-01
Q1 2019 72M +21.1M +41.4% Mar 31, 2019 10-Q 2019-05-02
Q4 2018 71.7M +35.9M +100% Dec 31, 2018 10-K 2020-02-26
Q3 2018 71.3M +42.8M +150% Sep 30, 2018 10-Q 2018-11-07
Q2 2018 60.7M +33M +119% Jun 30, 2018 10-Q 2018-08-09
Q1 2018 50.9M +27M +113% Mar 31, 2018 10-Q 2018-05-09
Q4 2017 35.8M +15M +72% Dec 31, 2017 10-K 2019-03-13
Q3 2017 28.5M +8.6M +43.2% Sep 30, 2017 10-Q 2017-11-08
Q2 2017 27.7M +8.42M +43.7% Jun 30, 2017 10-Q 2017-08-09
Q1 2017 23.9M +14.2M +147% Mar 31, 2017 10-Q 2017-05-10
Q4 2016 20.8M +11.1M +115% Dec 31, 2016 10-K 2018-03-07
Q3 2016 19.9M +10.1M +103% Sep 30, 2016 10-Q 2016-11-10
Q2 2016 19.3M +9.49M +97% Jun 30, 2016 10-Q 2016-08-11
Q1 2016 9.68M +3.68M +61.4% Mar 31, 2016 10-Q 2016-05-10
Q4 2015 9.68M +3.68M +61.4% Dec 31, 2015 10-K 2017-03-21
Q3 2015 9.78M Sep 30, 2015 10-Q 2015-11-05
Q2 2015 9.78M Jun 30, 2015 10-Q 2015-08-14
Q1 2015 6M Mar 31, 2015 10-Q 2015-06-12
Q4 2014 6M Dec 31, 2014 10-K 2016-03-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.